載入...
Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease
There are few established treatments for patients with non-small-cell lung cancer (NSCLC) with interstitial lung disease (ILD). The safety and efficacy of albumin-bound paclitaxel (nab-paclitaxel) in combination with carboplatin is uncertain, although the combination of carboplatin and paclitaxel is...
Na minha lista:
| 發表在: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574118/ https://ncbi.nlm.nih.gov/pubmed/28855994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1359 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|